United Laboratories International Holdings Ltd (fra:UNJ) Share Price

Company Profile

Business description
United Laboratories International Holdings Ltd is mainly engaged in the research and development, production and sales of pharmaceuticals. The company operates in three segments: Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Finished products segment, followed by Bulk medicine. The majority of the company's sales are generated in China, followed by Europe, India and other countries.
Contact
No. 6 Fuk Wang Street
Yuen Long Industrial Estate
New Territories
Hong Kong
HKG
T: +852 26871033
http://www.tul.com.cn
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
18,000

Recommended

Trading at an 18% discount, this wide-moat stock is a rare find.

Malik Ahmed Khan, CFA | 22 September 2026

Discounted exit raises investor concerns.

Yingqi Tan, CFA | 21 September 2026

The data and AI company is one of the world’s strongest private companies, but a PitchBook report says it’s unattractive at the current price.

Jacob Robbins | 21 September 2026

Index	Last price	Change	% Change
All Ordinaries	8,845.60	51.40	-0.58%
CAC 40	8,077.80	3.63	-0.04%
DAX 40	25,408.64	142.11	0.56%
Dow JONES (US)	51,828.62	478.64	0.93%
FTSE 100	10,695.25	15.26	0.14%
HKSE	24,510.09	251.04	-1.01%
NASDAQ	27,068.72	129.34	0.48%
Nikkei 225	66,364.20	850.21	1.30%
NZX 50 Index	13,811.11	13.72	-0.10%
S&P 500	7,743.41	39.28	0.51%
S&P/ASX 200	8,665.00	37.00	-0.43%
SSE Composite Index	3,888.37	48.15	-1.22%